Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
<p>Background: We compared the angiotensin receptor-neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. </p><p>Methods: In this double-blind trial, we randomly assigned 8442 patients with...
Saved in:
Main Author: | Mohammed Habib (Author) |
---|---|
Format: | Book |
Published: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2018-10-18.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart Failure (HF): Recent innovations in clinical therapy and critical profiles of acute and chronic forms
by: Giulio Perrotta
Published: (2022) -
The Role of Calcium Handling in Heart Failure and Heart Failure Associated Arrhythmias
Published: (2019) -
Topics in Heart Failure Management
Published: (2019) -
Diagnosis and Management of Heart Failure
Published: (2022) -
Bistatic HF Radar
Published: (2020)